Pfizer: Non-alcoholic Fatty Liver Disease trials
The registry lists 16 Non-alcoholic Fatty Liver Disease studies with Pfizer as lead sponsor. 0 are open to participants now and 11 have results posted.
Phase 1 9Phase 2 6No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Study in Healthy Adults Evaluating PF-07202954CompletedNCT04857437Phase 1Results posted
- Study of Multiple Oral Doses of PF-06835919 in Healthy Adult Japanese ParticipantsCompletedNCT04427917Phase 1Results posted
- Study of Pharmacodynamics and Safety of DGAT2i and ACCi Coadministered in Participants With Sponsor-defined Presumed Non Alcoholic SteatohepatitisCompletedNCT04399538Phase 2Results posted
- Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)CompletedNCT04321031Phase 2Results posted
- A STUDY TO COMPARE THE PHARMACOKINETICS OF PF-06835919 IN PARTICIPANTS WITH AND WITHOUT HEPATIC IMPAIRMENTCompletedNCT04193436Phase 1Results posted
- Effect Of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of PF-06865571 In Subjects With Hepatic Impairment and in Healthy SubjectsCompletedNCT04091061Phase 1Results posted
- A Double-blind Study to Assess 2 Doses of an Investigational Product for 16 Weeks in Participants With Non-alcoholic Fatty Liver Disease and Type 2 Diabetes MellitusCompletedNCT03969719Phase 2Results posted
- A Study To Assess Pharmacodynamics, Safety And Tolerability Of PF-05221304 And PF-06865571 Co-Administered For 6 Weeks In Adults With Non-Alcoholic Fatty Liver Disease.CompletedNCT03776175Phase 2Results posted
- 2-Week Study In People With Nonalcoholic Fatty Liver DiseaseCompletedNCT03513588Phase 1Results posted
- 6-week Safety and PD Study in Adults With NAFLDCompletedNCT03256526Phase 2Results posted
- Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD)CompletedNCT03248882Phase 2Results posted
- A Single and Multiple Dose Study of PF-05221304 in Healthy Japanese AdultsCompletedNCT03597217Phase 1
- Multiple Ascending Dose and DDI StudyCompletedNCT03031119Phase 1
- Single Dose of PF-06835919 Escalation Study in Healthy Adult SubjectsCompletedNCT02974374Phase 1
- Phase 1 Pharmacokinetic Study Of CP-945598 In Patients With NASHCompletedNCT00706537Phase 1
- Study Evaluating Metabolic Syndrome in Subjects Undergoing Gastric Bypass Bariatric SyndromeTerminatedNCT00283374